July 08, 2026 a 06:00 pm
JNJ: Fundamental Ratio Analysis - Johnson & Johnson
Johnson & Johnson (JNJ) is a strong player in the healthcare sector with a diversified portfolio under its Innovative Medicine and MedTech segments. The company is historically robust, consistently delivering solid financial performance. With its comprehensive approach to healthcare, JNJ remains a key asset in any conservative investor's portfolio.
Fundamental Rating
Johnson & Johnson holds a solid "B+" rating. Below is a breakdown of key score categories.
| Category | Score | |
|---|---|---|
| Discounted Cash Flow | 4 | |
| Return on Equity | 5 | |
| Return on Assets | 5 | |
| Debt to Equity | 1 | |
| Price to Earnings | 2 | |
| Price to Book | 1 |
Historical Rating
Current and historical scores help gauge the company's performance trend over time.
| Date | Overall | DCF | ROE | ROA | Debt/Equity | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2026-07-08 | 3 | 4 | 5 | 5 | 1 | 2 | 1 |
| N/A | 0 | 4 | 5 | 5 | 1 | 2 | 1 |
Analyst Price Targets
Analyst estimates show potential upside for the company’s stock price with optimistic and conservative viewpoints.
| High | Low | Median | Consensus |
|---|---|---|---|
| $290 | $208 | $265 | $256.31 |
Analyst Sentiment
The analyst sentiment for JNJ is positive, with a majority recommending a Buy.
| Recommendation | Count | |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 21 | |
| Hold | 16 | |
| Sell | 3 | |
| Strong Sell | 0 |
Conclusion
Johnson & Johnson remains a stable investment given its consistent performance and strong market presence in healthcare. While some metrics like P/E and debt to equity suggest room for improvement, the overall ratings indicate a company well-equipped to navigate market challenges. Analyst price targets and sentiment further affirm the favorable outlook. Investors should weigh these factors alongside industry risks such as regulatory changes and competition.
Smart Data Insight
Master the Perfect Entry & Exit for this Stock
Don't leave your profits to chance. Historically, this stock follows specific seasonal patterns that institutional traders use to maximize returns.
- ✅ Identify the "Golden Buying Window"
- ✅ Avoid high-risk correction cycles
- ✅ Backtested data from the last 20+ years